Literature DB >> 17662169

Invasive meningococcal disease in children in Jerusalem.

C Stein-Zamir1, N Abramson, G Zentner, H Shoob, L Valinsky, C Block.   

Abstract

Neisseria meningitidis is an important cause of childhood meningitis and septicaemia. Between 1999 and 2005, 133 invasive meningococcal disease (IMD) cases occurred in Jerusalem, 112 (84.2%) of them in children aged 0-14 years. The annual incidence rate in Jerusalem was higher than the national average (2.45+/-0.6 vs. 1.13+/-0.16/100 000 population, P=0.002). Most of the children (82.1%) were from low socio-economic Arab and Jewish ultra-orthodox communities; mortality was higher among Arab than Jewish children (1.3 vs. 0.22/100 000 person-years, P=0.004). A cluster of 10 children with severe meningococcal sepsis (three fatalities) emerged in the winter of 2003-2004. Compared to the other 102 cases in 1999-2005 both meningococcaemia (100% vs. 51%, P=0.003) and mortality (30% vs. 6.9%, P=0.014) rates were higher. Serogroup B comprised 77.6% of the bacterial isolates. Pulsed-field gel electrophoresis showed considerable variability among cluster isolates, but significant resemblance in Arab cases throughout 1999-2005. The increased susceptibility of specific sub-populations to IMD necessitates further evaluation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17662169      PMCID: PMC2870872          DOI: 10.1017/S0950268807009259

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  33 in total

Review 1.  Ascertainment of meningococcal disease in Europe.

Authors:  C Trotter; S Samuelsson; A Perrocheau; S de Greeff; H de Melker; S Heuberger; M Ramsay
Journal:  Euro Surveill       Date:  2005-12

Review 2.  Towards an improved serogroup B Neisseria meningitidis vaccine.

Authors:  Kirsten P Perrett; Andrew J Pollard
Journal:  Expert Opin Biol Ther       Date:  2005-12       Impact factor: 4.388

3.  The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease.

Authors:  Johan Holst; Berit Feiring; Lisbeth M Naess; Gunnstein Norheim; Paul Kristiansen; E Arne Høiby; Klaus Bryn; Philipp Oster; Paolo Costantino; Muhamed-Kheir Taha; Jean-Michel Alonso; Dominique A Caugant; Elisabeth Wedege; Ingeborg S Aaberge; Rino Rappuoli; Einar Rosenqvist
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

4.  From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease.

Authors:  Jane O'Hallahan; Diana Lennon; Philipp Oster; Robbie Lane; Stewart Reid; Kim Mulholland; Joanna Stewart; Liane Penney; Teuila Percival; Diana Martin
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

5.  Forty years of meningococcal disease in Israel: 1951-1990.

Authors:  C Block; M Roitman; B Bogokowsky; S Meizlin; P E Slater
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

6.  Population-based analysis of meningococcal disease mortality in the United States: 1990-2002.

Authors:  Akbar Sharip; Frank Sorvillo; Matthew D Redelings; Laurene Mascola; Matthew Wise; Dao M Nguyen
Journal:  Pediatr Infect Dis J       Date:  2006-03       Impact factor: 2.129

7.  Failure of mass antibiotic prophylaxis to control a prolonged outbreak of meningococcal disease in an Israeli village.

Authors:  S Shehab; N Keller; A Barkay; L Leitner; A Leventhal; C Block
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-11       Impact factor: 3.267

8.  The meningococcus tamed?

Authors:  A J Pollard; E R Moxon
Journal:  Arch Dis Child       Date:  2002-07       Impact factor: 3.791

9.  Risk factors for invasive disease among children in Spain.

Authors:  Inmaculada Pereiró; Javier Díez-Domingo; Leopoldo Segarra; Alfredo Ballester; Amparo Albert; Amparo Morant
Journal:  J Infect       Date:  2004-05       Impact factor: 6.072

10.  WINPEPI (PEPI-for-Windows): computer programs for epidemiologists.

Authors:  Joseph H Abramson
Journal:  Epidemiol Perspect Innov       Date:  2004-12-17
View more
  9 in total

1.  Clonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: emergence of new clone ST-4240/6688.

Authors:  Chivonne Moodley; Mignon du Plessis; Kedibone Ndlangisa; Linda de Gouveia; Keith P Klugman; Anne von Gottberg
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

2.  Cost-utility analysis of a nationwide vaccination programme against serogroup B meningococcal disease in Israel.

Authors:  Gary M Ginsberg; Colin Block; Chen Stein-Zamir
Journal:  Int J Public Health       Date:  2016-04-22       Impact factor: 3.380

3.  Dynamics of childhood invasive meningococcal disease in Israel during a 22-year period (1989-2010).

Authors:  S Ben-Shimol; R Dagan; Y Schonmann; N Givon-Lavi; N Keller; C Block; I Kassis; M Ephros; D Greenberg
Journal:  Infection       Date:  2013-03-10       Impact factor: 3.553

4.  An expanded age range for meningococcal meningitis: molecular diagnostic evidence from population-based surveillance in Asia.

Authors:  Soon Ae Kim; Dong Wook Kim; Bai Qing Dong; Jung Soo Kim; Dang Duc Anh; Paul E Kilgore
Journal:  BMC Infect Dis       Date:  2012-11-19       Impact factor: 3.090

5.  A cluster of invasive meningococcal disease revealed by the characterization of a novel serogroup B meningococcal clone.

Authors:  L Valinsky; J Jaffe; N Keller; C Block; N Abramson; C Stein-Zamir
Journal:  Epidemiol Infect       Date:  2015-06-26       Impact factor: 4.434

6.  Clinical characteristics and molecular epidemiology of children with meningitis in Tehran, Iran: a prospective study.

Authors:  A Pormohammad; S Lashkarbolouki; T Azimi; P Gholizadeh; N Bostanghadiri; H Safari; S Armin; N Mohtavinejad; F Fallah
Journal:  New Microbes New Infect       Date:  2019-08-29

7.  Prevalence and Characteristics of Carriage of Neisseria meningitidis Among Young Israeli Adults.

Authors:  Noa Sofer-Sali; Diana Roif-Kaminsky; Yair Motro; Boris Khalfin; Eva Avramovich; Inbal Galor; Amir Shlaifer; Adir Sommer; Ran Rutenberg; Yacov Sachter; Avraham Yitzhak; Daniel Grupel; Jacob Moran-Gilad
Journal:  Open Forum Infect Dis       Date:  2022-09-19       Impact factor: 4.423

8.  Bacterial Meningitis after Cochlear Implantation among Children without Polyvalent Conjugate Vaccine: A Brief Report of an Iranian Cohort Study on 371 Cases.

Authors:  Shahla Afsharpaiman; Susan Amirsalari; Mohammad Ajalloueyan; Amin Saburi
Journal:  Int J Prev Med       Date:  2014-08

9.  Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil.

Authors:  Márcia de Cantuária Tauil; Cleidiane Santos Rodrigues de Carvalho; Ataiza César Vieira; Eliseu Alves Waldman
Journal:  Braz J Infect Dis       Date:  2014-03-31       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.